CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-16 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Sale | −2,816 | $5.25 | $15K | 190,312 |
| 2026-03-16 | Magrath George Chief Executive Officer | Sale | −24,438 | $5.21 | $127K | 1,750,855 |
| 2026-03-16 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | −3,719 | $5.12 | $19K | 516,775 |
| 2025-12-09 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Sale | −4,000,000 | $2.15 | $8.6M | 5,492,171 |
| 2017-04-10 | Ahn Chang Ho Director | Sale | −250,000 | $0.70 | $175K | 6,010,000 |
| 2015-01-12 | Jeong Tae Heum Chief Financial Officer | Sale | −49,800 | $0.91 | $45K | 505,000 |
| 2015-01-12 | Ahn Chang Ho Director | Sale | −48,444 | $0.91 | $44K | 6,010,000 |
| 2015-01-09 | Jeong Tae Heum Chief Financial Officer | Sale | −188,690 | $0.92 | $173K | 505,000 |
| 2015-01-09 | Ahn Chang Ho Director | Sale | −186,212 | $0.92 | $170K | 6,010,000 |
| 2015-01-08 | Jeong Tae Heum Chief Financial Officer | Sale | −78,782 | $0.90 | $71K | 505,000 |
| 2015-01-08 | Ahn Chang Ho Director | Sale | −80,000 | $0.90 | $72K | 6,010,000 |
| 2014-06-12 | Ahn Chang Ho Director | Sale | −136,193 | $0.99 | $134K | 6,813,924 |
| 2013-09-09 | Jeong Tae Heum Chief Financial Officer | Sale | −71,139 | $0.46 | $32K | 505,000 |
| 2009-05-04 | Ahn Chang Ho Chairman & CEO | Sale | −2,600,000 | $0.68 | $1.8M | 10,260,000 |
| 2006-12-11 | Park Young Soon Director | Sale | −384,500 | $0.31 | $119K | 2,740,500 |
| 2005-01-11 | Ferraro Frank Director | Sale | −224,000,000 | $0.00 | $403K | 26,000,000 |
| 2005-01-11 | Ferraro Frank Director | Sale | −10,000,000 | $0.00 | $18K | 0 |
Page 2 of 2 · 37 trades